VistaGen Therapeutics
VTGN
#9209
Rank
NZ$0.12 B
Marketcap
$4.43
Share price
11.11%
Change (1 day)
-45.33%
Change (1 year)

Market capitalization of VistaGen Therapeutics (VTGN)

Market cap: NZ$0.12 Billion

As of December 2024 VistaGen Therapeutics has a market cap of NZ$0.12 Billion. This makes VistaGen Therapeutics the world's 9209th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VistaGen Therapeutics from 2011 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.12 B-43.85%
2023NZ$0.21 B554.56%
2022NZ$33.55 M-94.11%
2021NZ$0.57 B54.6%
2020NZ$0.36 B733.13%
2019NZ$44.26 M-36.27%
2018NZ$69.45 M102.76%
2017NZ$34.25 M-24.09%
2016NZ$45.12 M71.55%
2015NZ$26.3 M82.96%
2014NZ$14.37 M24.56%
2013NZ$11.54 M-32.79%
2012NZ$17.17 M-72.66%
2011NZ$62.81 M

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of VistaGen Therapeutics was reported to be:

NZ$0.12 Billion
by Nasdaq info icon info icon
NZ$0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$1.02 B 732.30%๐Ÿ‡บ๐Ÿ‡ธ USA